Cancer biomarker testing looks for specific features in a tumour or, in certain situations, the blood that may help doctors choose treatment. Results can include gene changes, proteins or other signals. Testing does not automatically identify a useful drug for every patient, and a negative result does not mean there are no treatment options. The tests recommended depend on the cancer type, stage and clinical circumstances.
What Is Biomarker Testing for Cancer?
A biomarker is a measurable biological feature. In oncology, a biomarker may help identify a cancer subtype, estimate prognosis or predict whether a treatment is likely to help. Biomarker testing is sometimes called molecular profiling, molecular testing or tumour profiling, although these terms can describe different panels and methods.
Why Might an Oncologist Recommend Biomarker Testing?
- To check whether a specific cancer medicine has evidence for your tumour
- To better classify a cancer when the diagnosis is complex
- To assess certain inherited implications when an appropriate specialist advises it
- To consider a clinical trial or another treatment option
- In selected cases, to investigate why treatment has stopped working
Not every biomarker provides all these answers. For a separate explanation of how clinicians use results when making treatment decisions, see how doctors decide whether targeted therapy is suitable.
What Are the Main Types of Cancer Biomarker Tests?
Immunohistochemistry (IHC)
IHC identifies certain proteins in a tumour sample. It can help pathologists classify the cancer and, for specific markers, guide treatment decisions.
Polymerase chain reaction (PCR) and other focused genetic tests
These tests look for selected genetic changes. They may be useful when the clinical team needs to check a particular mutation or alteration.
Next-generation sequencing (NGS)
NGS can examine multiple genes or other molecular features in one test. The number and type of alterations tested vary between panels. More genes on a panel do not automatically mean better care.
Liquid biopsy
Some blood-based tests look for tumour-derived DNA circulating in the blood. These can be useful for selected clinical questions, but they do not replace every tissue biopsy, and a negative blood result may not rule out a tumour alteration.
What Sample Is Needed for Biomarker Testing?
Often, the laboratory uses tissue previously collected during a biopsy or surgery. Occasionally a new tissue sample is needed because the original is insufficient or no longer answers the clinical question. Some tests use blood. Ask your team which sample is needed, whether existing pathology blocks or slides can be used, and whether there are risks associated with additional sampling.
How to Read Common Terms in Your Biomarker Report
| Term | Plain-English meaning | What to ask |
|---|---|---|
| Positive / detected | The laboratory found the stated feature according to that test’s criteria | What does this result mean for my particular cancer? |
| Negative / not detected | The feature was not found within the test’s detection limits | Does this rule anything out, or was the sample limited? |
| Variant of uncertain significance (VUS) | A genetic change whose clinical meaning is not established | Should it affect treatment now? |
| Actionable alteration | A finding that could influence a clinical decision | Is there evidence for a suitable medicine in my situation? |
| Insufficient sample | There was not enough suitable material for a reliable result | Can stored tissue be retested or is another sample needed? |
Reports vary by laboratory and method. Never assume that a word such as “positive” means the treatment will work, or that “negative” means treatment cannot help.
Which Biomarkers Might Patients Hear About?
Examples include EGFR and ALK in selected lung cancers, HER2 in certain breast and other cancers, and BRAF in some tumour types. Other markers may relate to immunotherapy decisions rather than targeted medicines. These are illustrations, not a checklist of tests everyone needs. Your oncologist should explain which results matter for your confirmed diagnosis.
How Long Do Biomarker Test Results Take?
Timing depends on the laboratory, test method, sample quality and whether tissue has to be retrieved from another hospital. Some focused tests return sooner than broad panels, but there is no universal turnaround time. Ask when the result is expected and whether treatment must begin before it arrives.
Does Biomarker Testing Mean Targeted Therapy Will Work?
No. Finding a biomarker is one piece of evidence. A medicine must be supported for the precise alteration, cancer type and treatment situation, and it may still not work for an individual patient. For a practical comparison of treatment approaches, read how targeted therapy differs from chemotherapy.
What If Your Results Show No Actionable Mutation?
Your care team may still discuss chemotherapy, surgery, radiotherapy, immunotherapy, hormone therapy or supportive care, depending on your cancer. Doctors may also consider whether the test covered the markers relevant to your case. Patients facing complex choices can review advanced cancer treatment options and stage 4 cancer treatment options.
Should You Get a Second Opinion on a Biomarker Report?
A second opinion can be useful if results are difficult to interpret, the sample was inadequate, recommended therapies differ or cancer has progressed. Specialists may need the original pathology report, relevant laboratory findings, imaging and a treatment history. Read more about when to consider a cancer second opinion and how online medical-report review works.
Questions to Ask When You Receive Your Report
- Which test was used and what alterations did it examine?
- Was the sample sufficient and was the result reliable?
- Which findings matter for my cancer type and stage?
- Is any result uncertain or unlikely to change my care?
- Does the report support an evidence-based treatment option?
- Would another test change the decision?
- Who will explain the results and next steps?
Preparing Reports for an Overseas Specialist Review
If you are comparing recommendations from different hospitals, retain the complete laboratory report, pathology documents, previous treatment records and relevant scans. Confirm whether an overseas team needs the original tissue blocks or slides and how they can be transferred securely. AGH’s care journey explains coordination steps.
How AGH Medical Can Support Patients
AGH Medical is not a hospital or diagnostic laboratory. It does not interpret genetic results as a treating clinician, order medicines or guarantee treatment eligibility. The team can help patients organise medical documents and coordinate appropriate specialist or hospital review enquiries. You can contact AGH Medical about possible next steps without committing to treatment.
Frequently Asked Questions
Is biomarker testing the same as genetic testing?
They overlap, but are not identical. Biomarker tests can examine genes, proteins or other features. Tumour testing may detect changes that are not inherited; hereditary testing raises different questions and may require genetic counselling.
Does every cancer patient need NGS?
No. The useful test depends on cancer type, stage, available tissue and the clinical question.
Can a blood test find every cancer mutation?
No. Blood-based tumour DNA tests have limitations, and some changes may not be detected even when present.
Can old biopsy tissue be tested?
Sometimes. The laboratory must determine whether enough suitable material remains for the requested test.
What does VUS mean?
It means a variant of uncertain significance. It should not automatically be treated as a proven actionable target.
Does a positive result guarantee a suitable cancer medicine?
No. Treatment depends on the exact finding, cancer diagnosis and clinical evidence.
Who should explain my results?
Your treating oncologist or an appropriately qualified specialist familiar with your diagnosis should interpret their significance.
Medical Sources and Disclaimer
Learn more from the National Cancer Institute: Biomarker Testing for Cancer Treatment and National Cancer Institute: Targeted Cancer Therapies.
Disclaimer: This content is for general informational purposes and does not replace medical advice, diagnosis or treatment. Always consult a qualified healthcare professional about whether testing or treatment is appropriate for you.
